Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

GomSpace and Unseen Labs enter into an Authorisation To Proceed valued at 5MSEK to ensure supply of critical components for future projects

Today, GomSpace signed an ATP to ensure availability of critical components for future projects under preparation. Given the situation with global supply chains and the semi-conductor market specifically the proactive will ensure continuity and certainty of future deliveries.   For more information, please contact: Niels Buus (CEO, GomSpace)Phone: +45 40 31 55 57E-mail: nbu @ gomspace.com About GomSpace Group ABThe company’s business operations are mainly conducted through the wholly-owned Danish subsidiary, GomSpace A/S, with operational office in Aalborg, Denmark.

Veidekke ASA: To build Majorstuhjemmene nursing home in Oslo

Veidekke has entered into a contract with Omsorgsbygg Oslo KF to demolish the existing structures and erect the new, environmentally-certified Majorstuhjemmene nursing home with 120 places in central Oslo. The commission is a design and build contract valued NOK 608 million excluding VAT.The new Majorstuhjemmene will achieve the Breeam Excellent classification, and construction work will be carried out with a goal of an emission-free construction site. Existing structures will be demolished, and there are plans to reuse a range of materials in the new building. The nursing home will

The effect of metabolic syndrome traits on atherosclerosis can be reduced by increasing cardiorespiratory fitness already in childhood

The deleterious effects of metabolic and cardiovascular risk factors on arterial health can be reduced by increasing cardiorespiratory fitness already in childhood, a new study suggests. The study also found that the traditional way of investigating whether excess body fat relates to poor arterial health may be insufficient in understanding the biology of disease, because better arterial health was associated with higher fat mass in children. Researchers from the University of Eastern Finland, the University of Exeter, and the University of Bristol carried out the study using data from

KEBNI RECEIVES AN ORDER FOR DRIVE AWAY ANTENNA SYSTEMS

KebNi AB (publ) receives an order for Drive Away Antenna Systems with an order value of EUR 297 352 (approximately MSEK 2.9)Stockholm, 24 August 2021 - KebNi announces today that they have received an order for Satmission Drive-Away antenna systems. The total order value is EUR 297 352 (approximately 2.9 MSEK). Torbjörn Saxmo, CEO for KebNi comments, "We are pleased to win this order and trust that our new customer will be satisfied with our state-of-the art antennas."

Our RDI unit in Lempäälä is looking for an RDI Manager for the Construction business area

We have been shaping the future since 1919. At Kiilto, we invest in the future by ambitiously developing the sustainability of our operations, encouraging innovation and taking care of the wellbeing of all Kiiltonians. We are committed to fulfilling Our Promise to the Environment, motivated by the genuine opportunity to make a difference both individually and together. In this way, we can create lasting success for our customers. Join us on our journey to our destination, the year 2080!          Our research, development and innovation unit in Lempäälä is looking for an   RDI

Climate protection - not an option, but an obligation

Since the beginning of industrialization, greenhouse gas emissions have reached a level that, without drastic action, will lead to global catastrophe. At breathtaking speed, we are heading for a scenario in which extreme weather events could become the order of the day. The current severe weather disasters leave no doubt about this - they not only permanently alter our climate, but also bring great suffering and loss to people around the world. A single person, or a single action, cannot change this situation? We think this attitude is wrong, because setting a good example can start a

Genetic Analysis AS receives preliminary approval for listing and publishes prospectus in connection with planned IPO

OSLO, NORWAY - 24 August 2021: Genetic Analysis AS (“GA” or “the Company”) hereby announces that the Company has received preliminary approval for listing on Spotlight Stock Market (“Spotlight”). The Company hereby also publishes prospectus in connection with planned initial public offering of units, which initially amounts to a maximum of approximately NOK 60.1 million (the “IPO”) and further a maximum of approximately NOK 43 million and NOK 57.7 million, before issue costs, through warrant exercise of TO 1 and TO 2. The subscription period for the IPO begins on Monday, 30 August 2021 and

Request for notice of an Extraordinary General Meeting

Shareholders in Inzile AB (publ) corresponding to 51.42 percent of the shares and votes in the company have submitted a request to convene an Extraordinary General Meeting in accordance with Chapter 7. 13§ 2 st. ABL. The request has been received in connection with the previously announced transaction between Inzile and QEV Tech Holdings, which has been informed on 21 June and 5 August, respectively. The company intends to work to convene an Extraordinary General Meeting with the aim of taking a stand on the deal with QEV Tech Holdings and deciding on a full election of the Board. It

Recipharm launches new laboratory to expand analytical services offering

Global contract development and manufacturing organisation (CDMO), Recipharm, has announced the completion of a new analytical laboratory at its facility in Bengaluru, India.  The new 370 m2 area is fully cGMP compliant and is equipped with state-of-the-art technology and instruments to cater for the rising demand from customers for the company’s stand-alone Recipharm Analytical Solutions™. Recipharm Analytical Solutions™ is designed to help customers with timely, reliable outsourced support for analytical services from concept through to commercial. The new laboratory will

Nordic Proptech Group and Home Solutions announce appointment of new CEO

The Board of Nordic Proptech Investment Services AB(NPTIS) is pleased to announce the appointment of Andreas Göth as the new Chief Executive Officer of the Nordic Proptech Group including Home Solutions with effect from August 9th 2021. Andreas Göth recently comes from the position as CEO of QleanAir AB.Andreas Göth has a broad and extensive experience from the indoor environmental industry. His insights include Business Development, R&D, Product Management, Marketing & Sales, Finance and Admin and Operations. Throughout his career he has been working for companies like Skandiabanken,

Ponsse´s innovative solutions for working on slopes

Ponsse’s cut-to-length forest machines have proved to be excellent harvesting solutions, also on steep slopes. Environmentally friendly and safe harvesting solutions for slopes are in high demand, especially when harvesting takes place in areas with varying terrain and steepness.“Our solutions are always based on our customers’ needs, and our forest machines designed for steep slopes are no exception. We test and develop them together with our customers in truly demanding conditions, for example, in China, Brazil, North America and in Central Europe,” says Marko Mattila, Sales, Service and

Biosergen’s application to start human clinical trials with BSG005 is approved

Tuesday, August 24, 2021: Biosegen  AB (“Biosergen” or the “Company”) today announced that it has received positive feed back from the Australian regulatory authorities on the  application to initiate a phase I study in Austrialia of the Company’s proprietary antifungal drug candidate BSG005. With the approval, Biosergen is ready to conduct its First in Man clinical trial with BSG005.Biosergen submitted the application for the clinical phase I safety and tolerability study in 72 healthy male volunteers in Australia in May. The trial is so-called a single ascending dose and a multiple

Prostatype ® P-score and prognostic evaluation in Prostate cancer to be presented at the largest Urology meeting in the world

-Results of the study from Skåne University Hospital selected to present during American Urology Congress 2021The American Urology Association congress 2021 is the largest and most important gathering of Urologists in the world, and Prostatype Genomics is very proud to share that one of our P-score clinical validation studies has been selected for presentation at the congress. Lidi Xu, Chief Technology Officer at Prostatype Genomics comments “We are very happy to have received this nomination; over- and under- treatment of prostate cancer patients is common, and a significant problem for

Traction gas springs – a new highly requested product group

Lesjöfors' product range is growing continuously. We can now also offer traction gas springs that provide immediate power and high safety in applications that require a controlled closing. The products are available both in the standard range and as well as custom-made adapted to individual requirements.A traction gas spring is different from a conventional gas spring since it is working in the opposite direction, which means that it contracts instead of being pushed out. Unloaded, the piston rod is inside the cylinder while as under load; the force works to pull the rod back into the

Clavister Appoints Specialist Camilla Törnblom as Marketing Director, Building a Solid Platform for Marketing

August 24, 2021 – Örnsköldsvik, Sweden – Clavister , a leader in high-performance cybersecurity solutions, today announces it has appointed specialist Camilla Törnblom as Marketing Director. To bring Clavister closer to its customers and partner, the company formed a new commercial department under the leadership of Chief Commercial Officer, Przemek Sienkiewicz. As part of that strategy, Törnblom joins to head the new marketing team, where she’ll be responsible for executing Clavister’s

The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

ALTIA PLC      STOCK EXCHANGE RELEASE    24 August 2021 AT 11:00 a.m. EEST THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. The Finnish Financial

Arcus: The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. Arcus: The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared

SMART WIRES ANNOUNCES NEW CFO AND EXPANDED LEADERSHIP TEAM

San Francisco, US: Global power technology company, Smart Wires is pleased to announce the appointment of Julie Andrews to the position of Chief Financial Officer, and further appointments to its Leadership team.Smart Wires’ innovative technology is gaining huge traction across the world, enabling system operators to control power flows and maximize the grid’s capacity for renewables. To continue to support the strong momentum it is seeing across key markets, the company has significantly strengthened its senior leadership team over the last quarter. Smart Wires has complemented its

Valmet to supply a multifuel boiler to Kipaş Kağit Sanayi Isletmeleri A.Ş.’s paper mill in Turkey

Valmet Oyj’s press release on August 24, 2021 at 11:00 a.m. EETValmet will supply a multifuel power boiler and auxiliary process equipment to Kipaş Kağit Sanayi Isletmeleri A.Ş.’s paper mill in Kahramanmaraş, Turkey. The new boiler will improve the reliability of the paper mill’s steam and electricity supply. Additionally, its steam production capacity will be sufficient for the mill’s future paper machine PM 4. The order was included in Valmet’s orders received of the second quarter 2021. Typically, the value of this kind of order is in the range of EUR 25–35 million. The boiler plant

Karstensens Shipyard again selects Wärtsilä propulsion solutions for newbuild fishing vessels

Wärtsilä Corporation, Press release, 24 August 2021 at 10.30 AM EESTThe technology group Wärtsilä’s strong relationship with the Danish ship builder Karstensens Shipyard is once again emphasised with main propulsion equipment orders for two new fishing vessels. During the past year alone, the Karstensens yard has selected Wärtsilä solutions for seven vessels. These latest orders were placed in July. A custom designed 77-metre overall length fishing vessel, the ‘Christina S’, will be owned and operated by the Fraserburgh, Scotland based Simpson family’s Christina S Fishing Company in

Capital increase in TORM due to exercise of Restricted Share Units as part of the Company’s incentive program

TORM plc (“TORM”) increases its share capital by 54,905 A-shares (corresponding to a nominal value of USD 549.05) as a result of the exercise of a corresponding number of Restricted Share Units. The capital increase is carried out without any pre-emption rights for existing shareholders or others. 54,905 of the new shares have been subscribed for in cash at DKK 43.4 per A-share, all with a nominal value of USD 0.01 each. The new shares are ordinary shares without any special rights and are negotiable instruments. The new shares give right to dividends and other rights in relation to

InDex Pharmaceuticals receives FDA clearance to start the phase III study CONCLUDE with cobitolimod

August 24, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced that the U.S. Food and Drug Administration (FDA) has given clearance to start the phase III clinical study CONCLUDE in the United States. The study will evaluate the efficacy and safety of the first-in-class TLR9 agonist cobitolimod for the treatment of moderate to severe left-sided ulcerative colitis.“The United States is the largest pharmaceutical market in the world, and to receive clearance from the FDA  to start the phase III study CONCLUDE with cobitolimod is an important milestone for InDex,” said Peter

Proven long-term effect for Dicot’s drug candidate

Press release: Uppsala, August 24, 2021. The pharmaceutical company Dicot now releases results from its latest animal study concluding that the drug candidate LIB-01 has a longer effect on erectile function than other drugs on the market today, and that the effect increases over time. The study outcome is a significant milestone for the LIB-01 project.As previously reported Dicot is conducting animal studies in collaboration with the French contract laboratory Pelvipharm, where the drug candidate LIB-01's effect on erectile function is tested in both healthy rats and in animal disease

There are no items matching the current filter
There are no more items matching the current filter
Back to top